Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Still as toxic as ever: PROVE ME WRONG. 1:150 R/S following cataclysmic crash from .07 to .0002. R/S changed PPS to .03 and brought OS down to well under 50M. Less than 6 months later, we’re diluted to an OS level that is quickly approaching 200M. THESE ARE FACTS.
This has largely been the case for the last 3 years—yet NOTHING has launched this: NOTHING. Rational people ask “why?”...
Those who look at this as “an investment” should consider the experience and lived history by those of us who thought the same thing 3 years ago—only to see a rise from .01 to .07, followed by a slow crash all the way down to .0002, a 1:150 R/S that took it artificially to .03, followed again by a crash to DEEP below .01 recently. Same “management/leadership”: BUYER BEWARE.
What’s shocking, shameful, and sad (at least to me) is that this “leadership” presented itself as understanding such things—but it’s been clear to me for at least 2 years that (1) they are in WAY over their heads, (2) they are not interested in the input/assistance of those who might help plan and drive DIFFERENT outcomes, and (3) they’re not even aware that much of this is even relevant to consider. RESULTS over a protracted period allow reasonable and intelligent people to infer these conclusions safely.
2 questions: what exactly would they (or anyone else) see as lucratively valuable—surely not a few thousand DIY-style syringe kits?; and if there IS more, why has CELZ itself not pursued the capitalization of these assets?
PPS is the only “graph” you need to understand
We’ve believed for 2+ years that Tim taking shares for salary meant something hugely positive for the company: someone forgot to tell the market.
Point of fact: if this were a serious publicly traded company, this “management team” would never even get CLOSE to the field. We invested on the premise that they were equipped, aggressive, and prepared to build a beastly company (remember Gershman and Said talking about “disruptive technology”?): we were WRONG.
Been hearing that shizzz for going on 3 years. No more talk, no credibility in this stock. Poster child for undercapitalized equity lacking clear and compelling business plan with management that can execute.
Those of us who have invested in CELZ have been duped, hoodwinked, and bamboozled—myself included. PROVE me wrong with objective outcomes, facts, and results...
I have no suit, but I imagine a good atty could find problems in the fact that certain individuals (who have since, perhaps not surprisingly, DISAPPEARED) seemed to pump CELZ on social media (complete with ticker symbol and alleged CaverStem efficacy) more than 2 years ago, after which the stock went from under .01 all the way to .07–followed by a R/S and INSANE tanking that continues to this very day.
Class-action suits tend to get folks’ attention...
Almost a year old.
Sadly, that would involve an even greater waste of energy and time: it is abundantly clear that they simply DO NOT CARE.
They should not be allowed to take investor money without being compliant with AT LEAST the 4 basic financial statements and, say, a quarterly PR to update on business activities and plans. Assets=liabilities (which for most businesses means largely money borrowed from banks and the like) + equity (i.e. stockholders’ equity in form of capital contributed to purchase stock. It’s time to put banks and shareholders on a TRULY more equal footing.
What ARE you talking about?
Depends on the meaning of words = subjective. What I do know OBJECTIVELY is that several principally-engaged individuals made statements (captured digitally for the record) talking of CaverStem efficacy and urging folks to “check out” CELZ. 2.5 years later we are awash in OS (again) with STILL no clear articulation of a business MODEL, no regular communication with their “patient and valued shareholders,” and a post-R/S PP down roughly 90% AFTER the 1:150–which was itself effected following a 95+% crash from .07. FACTS.
+1. Taking a cut from the selling of kits = extent of their revenue stream. Nothing for the patents (what’s the point in having patents that you cannot directly monetize?). No
We wonder they were so quiet all along—they didn’t want to generate buzz that was beyond what the underlying reality would support. I still come back to those principally-involved persons crowing on social media 2+ years ago = reckless (or worse)...
Not arguing or yelling anything anywhere, monte old friend. Just looking for one definitive indication of a business model/commercial plan etc. that the market validates unequivocally and unmistakably—JUST ONE. is that too much to ask?
Agree about the OS figure: one site shows (public) float at around 130MM shares, while TDA shows OS at 722MM.
Why would they take this private, and what would that mean for shareholders if they did? Would they be “bought out”?
Is this a legit company with long-term legs and self-sustaining business potential as a serious market force in the stem cell space, or not? For the last 2 years it’s looked like “not”—though many never tire of pointing to “the patents.” If they truly ARE valuable, then why does the market not seem to know (or care). It’s time for substance already—no more BS games (or worse yet INERTIA). Let’s see your hand...
There is a major crisis of credibility here—MAJOR. Zero transparency, zero accountability, zero commercial results that can be directly and demonstrably correlated with PPS. Moreover, “board of directors” is
made up only of 4 principals—no one
representing shareholder interests from the “outside.” And none of this has changed for over 2 years; what HAS changed is that naively loyal investors have been fleeced repeatedly. Buyer beware.
I’ve thought that for the last 2 years. Makes even less sense that they don’t charge the docs royalties, access fees, or whatever you might call it. To me that means AT LEAST one of the following is necessarily true: they have no idea how to capitalize on their product lines, or their product lines as such are not really easily commercialized (which would render them mere purveyors of kits—which is what we’re seeing). WHY are these kinds of questions not being asked unrelentingly???
When do they plan to generate REAL income—i.e. revenues NOT attributable to “changes in fair value of securities,” which in this case was caused by the R/S? Asking for a friend...
And to think that we fell for the bill of goods sold on here and actually believed that this could be something more than a micro-penny stock. I honestly don’t think they’re smart enough to have done this out of malfeasance—just sheer incompetence.
Spent 2 years consumed with this—on the grounds that it was launching. Experience is the best teacher. Largely ignoring this bunch until their RESULTS merit attention. Frankly wish I had made off with the $40K I’d made—but I bought into the hype around the idea that these guys were actually aggressive and focused: neither has proven true. They stink out loud.
When is the Q coming?? Due since April, no?? Insights??
Can’t get out of their own way—never could
And that’s STILL a big yawner: dilution has gotten worse AFTER the R/S—it’s something like 6-7x the OS compared to immediately after the R/S, and the PPS is DOWN ~85% in that period too. Under these circumstances, how can anyone look at this as an “investment” (to be held until the 9th of Never, when it will allegedly “pay off”)?
Context: take 135MM OS and * 150= 20 BILLION in terms of pre-R/S
The bottom line is that they have found no efficient and effective path toward implementation of their IP that would result in widespread market awareness of their brand and significant revenues. All this despite a political climate that could hardly be more receptive to their kinds of alternative therapies. It’s truly mind-boggling.
No shareholder update since October? When is the newest Q (postponed before) now due??
The death rate is roughly 2% and achieving herd immunity can only occur from wide social interaction—this is basic virology/immunology (look into Dr. Knut Wittkowski on this). Cautious confidence is in order.
Why does OTC markets still show CELZ as a “pink” Security when the R/S was explicitly sold as necessary in order to return to QB? That same source shows our new OS at ~136MM, up substantially from the post-R/S level...